Latest News
Biostar Pharmaceuticals, Inc. Announces Its Quarte...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017 XIANYANG, China, May 19, 2017 /PRNewswire/ - Biostar Pharmaceuticals, In...
 í˙ News & Media
09
Jan
2015
Biostar Pharmaceuticals, Inc. Announces Signing of Joint Research and Development Agreement with Northwest University for Further Development of Danshensu Yibingzhi (IDHP), a Class One Drug for Treatment of Cardiovascular Diseases
Biostar Pharmaceuticals, Inc. Announces Signing of Joint Research and Development Agreement with Northwest University for Further Development of Danshensu Yibingzhi (IDHP), a Class One Drug for Treatment of Cardiovascular Diseases       ...
14
Nov
2014
Biostar Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results
Biostar Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results XIANYANG, China, November 14, 2014 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer an...
18
Sep
2014
Biostar Pharmaceuticals, Inc. Files a PRC Patent Application for Oleanolic Acid Injection, its New Drug Product for Hepatitis B and Liver Cancer
               Biostar Pharmaceuticals, Inc. Files a PRC Patent Application for  Oleanolic Acid Injection, its New Drug Product for Hepatitis B and Liver Cancer        &n...
27
Aug
2014
Biostar Pharmaceuticals Inc. Engaged Chief Scientist Professor Xiaohui Zheng To Preside Over The Companyí»s Product Development Projects
Biostar Pharmaceuticals Inc. Engaged Chief Scientist Professor Xiaohui Zheng  To Preside Over The Companyí»s Product Development Projects Xianyang, China, August 27, 2014, /PRNewswire/-- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Comp...
14
Aug
2014
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results  Revenue increased by 31% to $19.2 million  Net income increased to $1.65&nbs...
04
Aug
2014
Biostar Pharmaceuticals Inc. Established a Sales and Marketing Task Team to Promote Sales to Hospital Facilities in Ten PRC Provinces
Biostar Pharmaceuticals Inc. Established a Sales and Marketing Task Team to Promote Sales to Hospital Facilities in Ten PRC Provinces Xianyang, China, Aug 04, 2014, /PRNewswire/-- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"),...
15
May
2014
Biostar Pharmaceuticals, Inc. Announces First Quarter 2014 Financial Results
Biostar Pharmaceuticals, Inc. Announces First Quarter 2014 Financial Results XIANYANG, China, May 15, 2014 /PRNewswire/Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (í░Biostarí▒ or í░the Companyí▒), a PRC-based manufacturer and marketer of pharmaceutical and health supple...
31
Mar
2014
Biostar Pharmaceuticals, Inc. Announces Full Year 2013 Financial Results
Biostar Pharmaceuticals, Inc. Announces Full Year 2013 Financial Results Annual Revenue Increased to $52.3 Million Net Income Increased to $809,046, or EPS of $0.06 in FY 2013 XIANYANG, China, March 31, 2014 /PRNewswire/ ? Biostar Pharmaceuticals...
10
Mar
2014
Biostar Announces Execution of Agreement for $4.1 Million Registered Direct Offering of Shares of Common Stock and Warrants
XIANYANG, China, March 10, 2014 ? Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (í░Biostarí▒ or í░the Companyí▒), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, announced today that it en...